6-Fluoro-2-hydrazinylbenzo[d]thiazole

Catalog No. :
ACSOIK213
CAS No. :
78364-55-3
Molecular Formula :
C7H6FN3S
Molecular Weight :
183.21

IUPAC Name:6-fluoro-2-hydrazineylbenzo[d]thiazole

6-Fluoro-2-hydrazinylbenzo[d]thiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g97%$70.00Login to see priceIn stockInquiry
25g97%$149.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Fluoro-2-hydrazinylbenzo[d]thiazole
IUPAC Name6-fluoro-2-hydrazineylbenzo[d]thiazole
MDL No.MFCD04448803
Molecular FormulaC7H6FN3S
Molecular Weight183.21
SMILESNNC1=NC2=CC=C(F)C=C2S1
InChI KeyQODXZESJVXQCSC-UHFFFAOYSA-N
Synonym6-FLUORO-2(3H)-BENZOTHIAZOLONE YDRAZONE;6-Fluro-2(3H)-benzothiazolone;2(3H)-Benzothiazolone,6-fluoro-,hydrazone(9CI);6-Fluoro-2(3H)-benzothiazolonehydrazone;(6-Fluoro-benzothiazol-2-yl)hydrazine;6-Fluoro-2-hydrazinylbenzo[d]thiazole;JR-8577, 1-(6-Fluorobenzo[d]thiazol-2-yl)hydrazine, 97%;(6-fluoro-1,3-benzothiazol-2-yl)hydrazine
CAS No.78364-55-3
PubChem CID2049844

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACSOIK213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJBTV619 route compound structure diagram
    ACJBTV619399-74-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSOIK213 route product structure diagram
    ACSOIK21378364-55-3 In Stock
Inquiry

2. ACSOIK213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZKGN167 route compound structure diagram
    ACZKGN167152937-04-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSOIK213 route product structure diagram
    ACSOIK21378364-55-3 In Stock
Inquiry

Comments (0)